TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | -7 | 2 | -12 | -25 | -20 | -10 |
| P | %wins | 50 | 0 | 100 | 0 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/16/21 09:57 | 12/15/21 | MRAI | Marpai, Inc. | NY | Health | Health | Misc Health & Allied Services | Bibring Yoram | FL | O | Cheif Fi | P | 22 | 4.33 | 0 | 5 | New | 5 | D | ||||||||||||||
8/21/15 09:00 | 8/20/15 | BCLI | Brainstorm Cell Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Bibring Yoram | NJ | O | CFO | P | 26 | 3.04 | 0 | 9 | 20 | 50 | D | 6 | -31 | -23 | -18 | -13 | -6 | 4 | 2 | -3 | -4 | 4 | -12 | -22 | -18 |
8/19/15 09:00 | 8/17/15 | BCLI | Brainstorm Cell Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Bibring Yoram | NJ | O | CFO | P | 121 | 2.92 | 0 | 42 | New | 42 | D | 10 | -30 | -17 | -15 | -9 | -2 | 11 | 5 | 1 | -10 | 0 | -12 | -28 | -21 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |